Description
3-Tert-butyl-5-methoxy-catechol exhibits anticancer activity, inhibiting proliferation of leukemia cells. This compound may also induce cellular differentiation in vitro.
Product Unit Size | Cost | Quantity | Stock |
---|
3-Tert-butyl-5-methoxy-catechol exhibits anticancer activity, inhibiting proliferation of leukemia cells. This compound may also induce cellular differentiation in vitro.
Cas No. | 80284-15-7 |
---|---|
Purity | ≥98% |
Formula | C11H16O3 |
Formula Wt. | 196.25 |
Chemical Name | 3-tert-butyl-5-methoxybenzene-1,2-diol |
IUPAC Name | 3-tert-butyl-5-methoxybenzene-1,2-diol |
Synonym | 3-(1,1-Dimethylethyl)-5-methoxy-1,2-benzenediol, 3-tert-Butyl-4,5-dihydroxyanisole |
Melting Point | 95-96°C |
Solubility | Partly soluble in water. |
Appearance | White/Off-white Crystalline Solid |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Tsuchiya T, Ishida A, Miyata N, et al. Effects of 3-tert-Butyl-4-hydroxyanisole and its hydroquinone and quinone metabolites on rat and human embryonic cells in culture. Toxicol In Vitro. 1988;2(4):291-6. PMID: 20837439.
Lam LK, Garg PK, Swanson SM, et al. Evaluation of the cytotoxic potential of catechols and quinones structurally related to butylated hydroxyanisole. J Pharm Sci. 1988 May;77(5):393-5. PMID: 3411459.
H+/K+ ATPase inhibitor.
Macrolide lactone antibiotic.
Pt-based DNA cross-linker.
Thiamine, coccidiostat; thiamine transporter in...
Taxol synthesis intermediate.
JAK2 inhibitor, potential EGFR inhibitor.
Endogenous peptide hormone fragment, involved i...
Peptide, oxytocin analog; potential OXTR agonis...
Non-selective CB receptor agonist.
Synthetic compound related to sulforaphane.
Mineralocorticoid antagonist.
Inhibitor of BMP.
Synthetic ITC.
Synthesis intermediate
Cannabinoid receptor 2 selective agonist.
5-Fluorouracil prodrug, pyrimidine nucleoside a...
Imidazole; 14-α demethylase inhibitor.
NSAID; COX-1/2 inhibitor.
Pt-based DNA cross-linker.
Imaging agent; Maillard reaction inhibitor.